The National Transplantation Pregnancy Registry (NTPR) was established in 1991 at Thomas Jefferson University, Philadelphia, PA to study the outcomes of pregnancies in female transplant recipients and those fathered by male transplant recipients.

More than 2000 recipients, reporting over 3300 pregnancies, have participated in the registry. Included are kidney, liver, liver-kidney, pancreas, heart, lung and small bowel recipients from throughout North America.

The NTPR is an ongoing study. Transplant coordinators, physicians and recipients are encouraged to submit a one-page recipient questionnaire regarding post-transplant pregnancies to the NTPR.

Support for the NTPR has been provided by grants from its founding sponsor, Novartis Pharmaceuticals Corporation, as well as Astellas Pharma US, Inc., Genentech, Inc., Pfizer Inc., Teva Pharmaceuticals USA, Sandoz Inc. and Bristol-Myers Squibb Company.

Contact Us:
1-877-955-6877 (toll-free)
215-955-4820

215-503-6856 (fax)

I would like to obtain more information